Enzene has invested in technologies of the future to allow fully integrated development, beginning with cell line engineering to drug product development. We have the state-of-the-art analytical lab for comprehensive characterization of mAbs, high throughput screening technologies in our upstream as well as downstream process development. We have a proprietary cloning platform and internal regulatory science, which caters to most of the filing requirements.
